Detalhe da pesquisa
1.
The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.
Blood
; 127(16): 1998-2006, 2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26869395
2.
Targeting the Ataxia Telangiectasia Mutated-null phenotype in chronic lymphocytic leukemia with pro-oxidants.
Haematologica
; 100(8): 1076-85, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25840602
3.
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.
Blood
; 116(22): 4578-87, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20739657
4.
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.
Exp Hematol
; 63: 52-63.e5, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656114
5.
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
Leukemia
; 32(9): 1984-1993, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29556024
6.
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival.
Blood
; 105(11): 4484-91, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15692065
7.
Rac1 and Rac2 GTPases in haematopoiesis.
Bioessays
; 26(3): 221-4, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14988923
8.
Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling.
Blood
; 104(5): 1465-73, 2004 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15142883
9.
Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses.
Blood
; 103(1): 291-300, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12958068